Evaluation of lncRNA Expression During the Differentiation of Mesenchymal Stem Cells to Insulin-Secreting Progenitors

Tina Shafaf; Sayed Reza Kazeminejad; Elham Hoveizi

doi:10.1007/s12035-023-03571-w

journal article Aug 23, 2023

Evaluation of lncRNA Expression During the Differentiation of Mesenchymal Stem Cells to Insulin-Secreting Progenitors

Tina Shafaf Sayed Reza Kazeminejad Elham Hoveizi

Molecular Neurobiology Vol. 61 No. 1 pp. 372-384 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s12035-023-03571-w

Topics

No keywords indexed for this article. Browse by subject →

References

30

[1]

Hoveizi E, Mohammadi T (2019) Differentiation of endometrial stem cells into insulin-producing cells using signaling molecules and zinc oxide nanoparticles, and three-dimensional culture on nanofibrous scaffolds. J Mater Sci Mater Med 30(9):101. https://doi.org/10.1007/s10856-019-6301-3 10.1007/s10856-019-6301-3

[2]

Gooraninejad S, Hoveizi E, Hushmandi K, Gooraninejad S, Tabatabaei SRF (2020) Small molecule differentiate PDX1-expressing cells derived from human endometrial stem cells on PAN electrospun nanofibrous scaffold: applications for the treatment of diabetes in rat. Mol Neurobiol 57:3969–3978 10.1007/s12035-020-02007-z

[3]

Zeka K, Alfa HH, Ruparelia KC, Arroo RR (2019) Use of natural products in the prevention and management of type 2 diabetes. Stud Nat Prod Chem 63:197–210 10.1016/b978-0-12-817901-7.00007-1

[4]

Abels M, Riva M, Shcherbina L, Fischer A-HT, Banke E, Degerman E, Lindqvist A, Wierup N (2022) Overexpressed beta cell CART increases insulin secretion in mouse models of insulin resistance and diabetes. Peptides 151:170747 10.1016/j.peptides.2022.170747

[5]

Memon B, Abdelalim EM (2020) Stem cell therapy for diabetes: beta cells versus pancreatic progenitors. Cells 9(2):283 10.3390/cells9020283

[6]

Zhou Z, Zhu X, Huang H, Xu Z, Jiang J, Chen B, Zhu H (2022) Recent progress of research regarding the applications of stem cells for treating diabetes mellitus. Stem Cells Dev 31(5-6):102–110 10.1089/scd.2021.0083

[7]

Elham H, Mahmoud H (2018) The effect of pancreas islet-releasing factors on the direction of embryonic stem cells towards Pdx1 expressing cells. Appl Biochem Biotechnol. https://doi.org/10.1007/s12010-018-2733-3 10.1007/s12010-018-2733-3

[8]

Hoveizi E, Tavakol S, Shirian S, Sanamiri K (2019) Electrospun nanofibers for diabetes: tissue engineering and cell-based therapies. Curr Stem Cell Res Ther 14(2):152–168 10.2174/1574888x13666181018150107

[9]

Solis MA, Moreno Velásquez I, Correa R, Huang LL (2019) Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America. Diabetol Metab Syndr 11(1):1–13 10.1186/s13098-019-0415-0

[10]

Rogal J, Zbinden A, Schenke-Layland K, Loskill P (2019) Stem-cell based organ-on-a-chip models for diabetes research. Adv Drug Deliv Rev 140:101–128 10.1016/j.addr.2018.10.010

[11]

Sneddon JB, Tang Q, Stock P, Bluestone JA, Roy S, Desai T, Hebrok M (2018) Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell 22(6):810–823 10.1016/j.stem.2018.05.016

[12]

Motterle A, Gattesco S, Caille D, Meda P, Regazzi R (2015) Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice. Diabetologia 58(8):1827–1835 10.1007/s00125-015-3641-5

[13]

How do lncRNAs regulate transcription?

Yicheng Long, Xueyin Wang, Daniel T. Youmans et al.

Science Advances 2017 10.1126/sciadv.aao2110

[14]

Ismail N, Abdullah N, Abdul Murad NA, Jamal R, Sulaiman SA (2021) Long non-coding RNAs (lncRNAs) in cardiovascular disease complication of type 2 diabetes. Diagnostics 11(1):145 10.3390/diagnostics11010145

[15]

Font-Cunill B, Arnes L, Ferrer J, Sussel L, Beucher A (2018) Long non-coding RNAs as local regulators of pancreatic islet transcription factor genes. Front Genet 524 10.3389/fgene.2018.00524

[16]

Wong WK, Sørensen AE, Joglekar MV, Hardikar AA, Dalgaard LT (2018) Non-coding RNA in pancreas and β-cell development. Non-coding RNA 4(4):41 10.3390/ncrna4040041

[17]

Morán I, Akerman I, Van De Bunt M, Xie R, Benazra M, Nammo T, Arnes L, Nakić N et al (2012) Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab 16(4):435–448 10.1016/j.cmet.2012.08.010

[18]

Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks

Ildem Akerman, Zhidong Tu, Anthony Beucher et al.

Cell Metabolism 2017 10.1016/j.cmet.2016.11.016

[19]

Guo J, Liu Z, Gong R (2019) Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease. Clin Sci 133(12):1321–1339 10.1042/cs20190372

[20]

The Impact of lncRNAs in Diabetes Mellitus: A Systematic Review and In Silico Analyses

Cristine Dieter, Natália Emerim Lemos, Nathalia Rodrigues de Faria Corrêa et al.

Frontiers in Endocrinology 2021 10.3389/fendo.2021.602597

[21]

Chen Y, He Y, Zhou H (2020) The potential role of lncRNAs in diabetes and diabetic microvascular complications. Endocr J 67:EJ19-0574 10.1507/endocrj.ej19-0574

[22]

Paladino FV, Peixoto-Cruz JS, Santacruz-Perez C, Goldberg AC (2016) Comparison between isolation protocols highlights intrinsic variability of human umbilical cord mesenchymal cells. Cell Tissue Bank 17(1):123–136 10.1007/s10561-015-9525-6

[23]

Corritore E, Dugnani E, Pasquale V, Misawa R, Witkowski P, Lei J, Markmann J, Piemonti L et al (2014) β-cell differentiation of human pancreatic duct–derived cells after in vitro expansion. Cell Reprogram (Formerly “Cloning and Stem Cells”) 16(6):456–466

[24]

Kim D-W, Staples M, Shinozuka K, Pantcheva P, Kang S-D, Borlongan CV (2013) Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 14(6):11692–11712 10.3390/ijms140611692

[25]

Mimura I, Nangaku M (2023) Epigenetic regulation of angiogenesis and ischemic response by long noncoding RNA LEENE in diabetes. Kidney Int 23:00483-0

[26]

Lim JE, Hong K-W, Jin H-S, Kim YS, Park HK, Oh B (2010) Type 2 diabetes genetic association database manually curated for the study design and odds ratio. BMC Med Inform Decis Mak 10(1):1–12 10.1186/1472-6947-10-76

[27]

βlinc1 encodes a long noncoding RNA that regulates islet β-cell formation and function

Luis Arnes, Ildem Akerman, Dina A. Balderes et al.

Genes & Development 2016 10.1101/gad.273821.115

[28]

Khoo C, Yang J, Weinrott SA, Kaestner KH, Naji A, Schug J, Stoffers DA (2012) Research resource: the pdx1 cistrome of pancreatic islets. Mol Endocrinol 26(3):521–533 10.1210/me.2011-1231

[29]

Kameswaran V, Bramswig NC, McKenna LB, Penn M, Schug J, Hand NJ, Chen Y, Choi I et al (2014) Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab 19(1):135–145 10.1016/j.cmet.2013.11.016

[30]

Shahjalal HM, Shiraki N, Sakano D, Kikawa K, Ogaki S, Baba H, Kume K, Kume S (2014) Generation of insulin-producing β-like cells from human iPS cells in a defined and completely xeno-free culture system. J Mol Cell Biol 6(5):394–408 10.1093/jmcb/mju029

Metrics

1

Citations

30

References

Details

Published: Aug 23, 2023
Vol/Issue: 61(1)
Pages: 372-384
License: View

Authors

T

Tina Shafaf

S

Sayed Reza Kazeminejad

E

Elham Hoveizi

Funding

Shahid Chamran University of Ahvaz Award: 1401

Cite This Article

Tina Shafaf, Sayed Reza Kazeminejad, Elham Hoveizi (2023). Evaluation of lncRNA Expression During the Differentiation of Mesenchymal Stem Cells to Insulin-Secreting Progenitors. Molecular Neurobiology, 61(1), 372-384. https://doi.org/10.1007/s12035-023-03571-w

Evaluation of lncRNA Expression During the Differentiation of Mesenchymal Stem Cells to Insulin-Secreting Progenitors

You May Also Like